An outbreak of respiratory tract diseases which can be traced back to an infection with a new type of coronavirus (2019-nCoV) was identified in Asia.
Read More

Today, phenols are used to produce medicines, paints, and inexpensive furniture made of chipboard or MDF panels and also to process food. Some of them are capable of imparting a pleasant smoky aroma to food, so they are often added to sausage or fish.
Read More

University of Maryland School of Medicine’s Institute for Genome Sciences researchers have created the first catalog of genes that comprise the community of microbes, which inhabit the human vagina.
Read More

The best approach for surgeons to identify malnourished cancer patients before they have a cancer operation may be specifically related to the type of cancer the patient has, according to researchers who found that common definitions of malnutrition do not apply equally to all cancers in assessment of preoperative risk.
Read More

A new special issue of the journal The Gerontologist from The Gerontological Society of America explores how contemporary trends in immigration, migration, and refugee movement affect how people age and how societies care for aging people.
Read More

Amid the global health crisis of the coronavirus (COVID-19), scientists from around the world are racing to find a treatment to stop the deadly virus. The sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread across 46 countries, infecting more than 82,000 and killing more than 2,800 people.
Read More

Walking and running subjects our feet to forces in excess of body weight. The longitudinal arch of the feet was thought to be the reason the feet do not deform under such load.
Read More

Mount Sinai Health System physicians–the first experts in the country to analyze chest computed tomography (CT) scans of patients from China with coronavirus disease (COVID-19)–have identified specific patterns in the lungs as markers of the disease as it develops over the course of a week and a half.
Read More

APEIRON Biologics AG, a biotechnology company with an approved product on the market as well as a broad preclinical and clinical pipeline, today announced the launch of a Pilot investigator-initiated clinical trial with APN01, a recombinant human angiotensin-converting enzyme 2, to treat patients with severe coronavirus infection in the People’s Republic of China.
Read More

Over the past two months, China has grappled with thousands of coronavirus deaths and infections. Through January and early February, the country reported thousands of new infections each day. Though the number of new infections has declined steadily, that is not the case outside China
Read More